Connect with us

Cannabis News

Youth Marijuana Use Has Declined Since Canada Enacted Legalization, Federally Funded Study Shows

Published

on

A federal study funded by Canada shows that youth marijuana use rates have dropped since the country legalized cannabis, countering concerns raised by prohibition.

Using data from Canada’s annual COMPASS Study, researchers from the University of Waterloo and Brock University compared trends in marijuana use among teenagers in 2017-2018 (pre-legalization) and 2021-2022 (post-legalization).

The study, published in the journal Addictive Behaviors Reports, found that 15 percent of students in the pre-legalization cohort reported past-month cannabis use, compared to 12.3 percent of the post-legalization cohort. Additionally, accounts of students who said they never used marijuana “increased” in this latter demographic.

In addition to examining rates of cannabis use, the researchers also sought to identify “risk factors” that may predict whether a student will use marijuana. And these factors changed between the two groups before and after legalization, which “suggests that prevention efforts need to be adjusted over time to target important risk factors associated with cannabis use.”

Specifically, it has to analyze Among more than 65,000 students across the two periods, although many risk factors were “common across the years,” “the relative ranking of risk factors changed significantly.”

“The main predictors of current (pre-legalization) cannabis use were time spent texting/messaging, daily breakfast consumption, and time spent doing housework, all of which also remained significant predictors in 2021-22,” the study authors said. “The main predictors of current (post-legalization) cannabis use were depression, a happy home life…and students’ perception that getting good grades was important.”

“Our results highlight an increase in reports of ever using cannabis and a slight decrease in current cannabis use in our sample,” the study says. “While this is in contrast to the evidence of higher levels of cannabis use among young people during the early stages of the COVID-19 pandemic, it is possible to argue that the declines observed here (years after pandemic-related restrictions) may not be due to the pandemic itself, but likely due to regulations related to legalization and/or changes in social norms.”

“Given that cannabis use remains common among young people, there is a great need to identify the characteristics of young people who are at greatest risk for cannabis misuse and, at the same time, to develop and expand prevention and early intervention programs tailored to the needs of these high-risk youth. This study demonstrates that, over a short period of 4 years, the pre-cannabis legalization period, the pre-cannabis legalization period, the post-cannabis legalization era. the profile of risk factors has changed significantly, increasingly involving mental health conditions.

The COMPASS Study is funded by the Canadian Institutes of Health Research and the Quebec Ministry of Health and Social Services.

German officials released the study after three months released a report on their country’s experience with national marijuana legalization.

That report found that opponents’ fears about youth use — as well as traffic safety and other concerns — are so far unfounded.

A separate recent study by German federal health officials also found this Marijuana use rates fell among young people after the country legalized adult use of cannabiscontradicting one of the most common prohibitionist arguments against reform.

In July, federal health data also indicated that marijuana use in the U.S. has increased in recent years. increase “driven by increases … among adults 26 and older.” For young Americans, rates of past-year use and cannabis use disorder, on the other hand, “remained stable among adolescents and young adults between 2021 and 2024.”

In the US, research suggests that youth marijuana use has declined in states that have legalized the drug for adults.

A report by the advocacy group Marihuana Policy Project (MPP), for example, found that Youth marijuana use has declined in 19 of the 21 states that legalized adult use—Adolescent cannabis use has dropped an average of 35 percent in the first states to legalize it.

The report cited data from a number of national and state youth surveys, including the annual Monitoring the Future (MTF) Survey, which is supported by the National Institute on Drug Abuse (NIDA).

The latest version of the MTF, released late last year, found that cannabis use among eighth, 10th and 12th graders is now on the rise. lower than before states began enacting laws to legalize adult use in 2012 Young people’s perception that cannabis is easy to obtain also declined significantly in 2024 despite an expanding market for adult use.

Another survey conducted last year by the US Centers for Disease Control and Prevention (CDC) also showed that a The proportion of high school students reporting marijuana use in the past month has decreased in the past decade, when dozens of states moved to legalize cannabis.

At the state level, MPP’s assessment looked at studies such as the Washington State Healthy Youth Survey released in April 2024.

That survey found a decline in lifetime and past 30-day marijuana use in recent years. They remained stable until 2023 with significant decreases. The results also indicated that the ease of access to cannabis among underage students has generally decreased since the state enacted adult legalization in 2012, contrary to fears repeatedly expressed by opponents of the policy change.

And in June of last year, the two-year Healthy Kids Colorado Survey found just that Statewide youth marijuana use rates fell slightly in 2023—Remains significantly lower than before the state became one of the first in the U.S. to legalize adult cannabis in 2012.

The findings follow other past surveys that have investigated the relationship between marijuana and jurisdictions that have legalized youth cannabis use.

For example, a Canadian government report recently found daily or near-daily usage rates among adults and youth. remained stable in the last six years after the country passed legalization.

Another US study found that a “Significant reduction” in youth marijuana use from 2011 to 2021.— a period when more than a dozen states legalized marijuana for adults — that determined lower rates of lifetime and past-month use among high school students nationwide.

Another federal report released last summer concluded Between 2022 and 2023, cannabis consumption among minors — defined as people between 12 and 20 years old — has fallen slightly..

Additionally, a research letter published in April 2024 by the Journal of the American Medical Association (JAMA) said there is no evidence. States passing laws to legalize and regulate marijuana for adults has increased youth use. of cannabis

Another study published by JAMA earlier this month also found that neither legalization nor the opening of retail shops led to an increase in youth cannabis use.

In 2023, however, a US health official said that adolescent marijuana use has not increased “even as state legalization proliferates across the country.”

Another study by the US Centers for Disease Control and Prevention found that Rates of current and lifetime cannabis use among high school students they have continued to decline amid the legalization movement.

A separate NIDA-funded study published in the American Journal of Preventive Medicine in 2022 also found that at the state level The legalization of cannabis was not accompanied by an increase in youth use. The study found: “Young people who spent their adolescence under legalization were no more or less likely to have used cannabis by age 15 than adolescents who spent little or no time under legalization.”

Another 2022 study by Michigan State University researchers, Published in the journal PLOS Onefound that “retail sales of cannabis may increase exposure to cannabis for older adults” in legal states, “but not for minors who cannot purchase cannabis products at a retail outlet.”

Although trends were observed adult use of marijuana and certain psychedelics reaching “historic highs.” in 2022, according to separate data for 2023.

Photo by Chris Wallis // Side Pocket Images.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Cannabis News

Swiss company launches nationwide price comparison tool for cannabis

Published

on

By











Evidena Care AG is one of the leading Swiss telemedicine platforms and specialized medical practices for medical cannabis. The company currently supports more than 2,000 patients across the country. Under the direction of Dr. Nicolai Berardi and two other specialist doctors, Evidena Care has focused on evidence-based, responsible and patient-centered treatment for the past two years.

Now, Evidena Care is launching a nationwide online comparison portal for medical cannabis products. The platform is designed for patients who already have a valid medical prescription and want a clear and reliable view of the market. For the first time in Switzerland, patients can directly compare products and prices from the country’s largest pharmacies in one place.

Medical cannabis plays an essential role in the treatment plans of many patients. At the same time, prices can vary significantly between pharmacies, even when the products contain the same levels of active ingredients. As these costs are often not covered by health insurance, or only partially covered, many patients have a heavy financial burden. The new portal addresses this issue by bringing transparency to a market that until now has been difficult to navigate.

The platform provides an overview of available products and dosages, clearly lists the active ingredient content, such as THC and CBD levels, and displays the current prices of leading Swiss pharmacies. Patients can directly compare options and make informed decisions that help optimize their therapy costs, without compromising medical guidance.

“Patients should not be victims of non-transparent pricing structures,” says Dr. Nicolai Berardi, CEO of Evidena Care AG. “We are creating transparency with our comparison portal, strengthening the self-responsibility of those affected and promoting fair competition in the interests of patients.”

The portal is only for people with a valid prescription. It serves as a true information tool and supports cost optimization in an existing therapy supervised by a physician.

For more information:
Evidena Care AG
Email: (email protected)
https://evidena.care/










Continue Reading

Cannabis News

Virginia Lawmakers Advance Marijuana Resentencing Bills As Push To Legalize Commercial Sales Also Nears Finish Line

Published

on

By

Virginia’s House and Senate lawmakers have advanced a pair of bills with amendments that would allow people with prior marijuana convictions to be sentenced.

Members of the Senate and House Judiciary Committees on Monday approved alternate versions of the reform bill in opposite chambers, setting the stage for bicameral negotiations as the measures move through the legislative process.

Broadly, the legislation introduced in both chambers would create a process to consider changing the sentences for people incarcerated or on community supervision for certain crimes involving the possession, manufacture, sale or distribution of marijuana.

The Senate panel approved it HB 26 In a 9-6 vote by Del. Rozia Henson (D), with revisions largely consistent with the House bill, SB 62that is being backed by Senate President Pro Tem Louise Lucas (D). passed on the floor last month before going Home.

Senators have now referred the House measure to the Senate Finance and Appropriations Committee for further consideration.

There are some differences between the sizes of the chambers. The House-passed legislation includes minors who would be eligible for relief from marijuana-related convictions, clarifies that judges would only consider convictions for cannabis offenses and specifies that the reform would include people with marijuana-related probation violations.

Both proposed bills apply to people with convictions or convictions for conduct that occurred before July 1, 2021, when a state law legalizing personal possession and home cultivation of marijuana went into effect.




As for the Senate bill, which clean up The House committee’s 15-7 vote Monday would have eliminated more categories of people who could be eligible for the sentence as an alternative, and would add a longer list of violent crimes that make people with cannabis convictions ineligible for relief.

Against the background of these recent developments, Virginia bills to legalize the sale of recreational marijuana have moved forward in the way of implementing laws. Last week, members of the Chamber of Deputies and the Senate modified and advanced the proposals of the opposite chambers on the subject.

Members of the Virginia Legislature Last month, he took action on multiple marijuana bills during a major deadline—advance proposals to legalize the sale of cannabis, provide a way to punish previous marijuana convictions, as well as other laws to allow access to medical cannabis for seriously ill patients in hospitals.

Despite their stark differences, the two chambers’ trade sales bills have largely aligned with recommendations released by the legislature in December. Joint Committee to Oversee the Transition to the Commonwealth Retail Cannabis Market.

Meanwhile, some members of the GOP have aligned ideologically with their Democratic colleagues throughout this legislative process, breaking with the majority of their caucus. in favor of creating a regulated market for adults to buy cannabis.

Since legalizing cannabis ownership and home cultivation in 2021, Virginia lawmakers have been working to establish a commercial marijuana market– Only for those efforts to stall under former Gov. Glenn Youngkin (R), who twice vetoed measures sent to his desk by the Legislature.

Gov. Abigail Spanberger (D), on the other hand, supports legalizing the sale of marijuana to adults.

Separately last month, the Virginia House patients passed a bill to allow the use of medical marijuana in hospitals. It would require health care facilities to implement policies “to address the situation in which an eligible patient is authorized to use medical cannabis.”

The Senate passed various pieces of legislation use of medical cannabis in healthcare facilities last month


It’s Marijuana Time tracking hundreds of cannabis, psychedelic and drug policy bills in state legislatures and Congress this year. Patreon supporters by pledging at least $25/month, you’ll get access to our interactive maps, charts, and audio calendars so you never miss a development.


Learn more about our marijuana bill tracking and become a Patreon supporter to gain access

Meanwhile, the Virginia House passed the bill earlier this month Protecting the rights of parents who use marijuana by complying with state laws.

Del. According to the proposal by Nadarius Clark (D), a parent or guardian’s own use of cannabis “shall not serve as a basis for a finding of abuse or neglect of a child unless other facts establish that its possession or consumption causes or produces physical or mental injury to the child.”

“A person’s legal possession or consumption of substances permitted (under state marijuana law) shall not serve as a basis for limiting custody or visitation unless other facts establish that such possession or consumption is not in the best interest of the child,” reads the text of HB 942.

Separately, the Virginia Department of Labor and Industry has published a new defining workplace protections for cannabis users.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Continue Reading

Cannabis News

State counties could tax medical marijuana sales under a new House bill

Published

on

By











A bill that would allow Oklahoma counties to impose a tax on retail marijuana sales has passed a committee in the Oklahoma House of Representatives.

Under the Oklahoma Legislature, House Bill 3314, authored by Rep. Ryan Eaves, R-Atoka, would allow counties to impose a tax of 15 percent of the impact of public utilities within county boundaries. The bill is similar to Senate Bill 1125, introduced by state Sen. Dusty Deevers, R-Elgin, in the Oklahoma Senate during the 2025 legislative session. SB 1125 would allow counties and municipalities to levy an excise tax on medical marijuana.

HB3314 passed the House County and Municipal Government Committee on a 6-0 vote, and now moves to the Government Oversight Committee for further consideration. The invoice does not automatically generate tax. If a county chooses to join, it must first be approved by a majority of the county’s voters in a special election. The bill also exempts marijuana grown on private property by individuals and not sold.

“Countries are the ones dealing with the daily impact of marijuana sales,” Eaves said. “This allows local communities to decide for themselves whether they want to allocate a portion of that revenue to law enforcement, first responders and improving problem properties.”

Read more at News 9










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media